GABAergic signaling as therapeutic target for autism spectrum disorders
about
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersK-Cl cotransporters, cell volume homeostasis, and neurological diseaseBrain-specific transcriptional regulator T-brain-1 controls brain wiring and neuronal activity in autism spectrum disordersPremature changes in neuronal excitability account for hippocampal network impairment and autistic-like behavior in neonatal BTBR T+tf/J mice.MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders.Early postnatal GABAA receptor modulation reverses deficits in neuronal maturation in a conditional neurodevelopmental mouse model of DISC1.Inhibition in the Human Auditory Cortex.Enhanced olfactory sensitivity in autism spectrum conditionsEpilepsy and intellectual disability linked protein Shrm4 interaction with GABABRs shapes inhibitory neurotransmissionEffects of chronic inhibition of GABA synthesis on attention and impulse control.Genetic Evidence for Possible Involvement of the Calcium Channel Gene CACNA1A in Autism Pathogenesis in Chinese Han Population.Estrogen administration modulates hippocampal GABAergic subpopulations in the hippocampus of trimethyltin-treated rats.Is functional brain connectivity atypical in autism? A systematic review of EEG and MEG studiesKinase-KCC2 coupling: Cl- rheostasis, disease susceptibility, therapeutic target.The GABAergic Hypothesis for Cognitive Disabilities in Down SyndromeTranslational potential of astrocytes in brain disorders.Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.Genetic Polymorphism of GABRR2 Modulates Individuals' General Cognitive Ability in Healthy Chinese Han People.The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.New treatment perspectives in autism spectrum disorders.Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibitionSimultaneous two-photon imaging of intracellular chloride concentration and pH in mouse pyramidal neurons in vivo.Subsequent maternal separation exacerbates neurobehavioral abnormalities in rats neonatally exposed to sevoflurane anesthesia.Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.Role of environmental stressors in determining the developmental outcome of neonatal anesthesia.K+-Cl- co-transporter 2 (KCC2) - a membrane trafficking perspective.Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex.GABAergic mechanisms involved in the prepulse inhibition of auditory evoked cortical responses in humans.Maternal Exposure to Valproic Acid Primarily Targets Interneurons Followed by Late Effects on Neurogenesis in the Hippocampal Dentate Gyrus in Rat Offspring.A kainate receptor subunit promotes the recycling of the neuron-specific K+-Cl- co-transporter KCC2 in hippocampal neurons.Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability.Delays in GABAergic interneuron development and behavioral inhibition after prenatal stress.Gamma oscillatory activity in vitro: a model system to assess pathophysiological mechanisms of comorbidity between autism and epilepsy.Bumetanide for autism: more eye contact, less amygdala activation.GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain.Shank2 Deletion in Parvalbumin Neurons Leads to Moderate Hyperactivity, Enhanced Self-Grooming and Suppressed Seizure Susceptibility in Mice.Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of AutismEffects of combined brief etomidate anesthesia and postnatal stress on amygdala expression of Cl cotransporters and corticotropin-releasing hormone and alcohol intake in adult ratsSocial Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic AgentsAssociation study and mutation sequencing of genes on chromosome 15q11-q13 identified GABRG3 as a susceptibility gene for autism in Chinese Han population
P2860
Q26796321-825C82C6-E77F-4B2C-8CCF-095E1D3A9D2FQ26825823-E32EBC6E-ACBE-41C4-9BAB-F28F5EBBBD88Q27001037-433D075A-DF5C-4956-B087-FD982702C1F5Q27316607-45731AC7-B1FB-4D56-8EFA-23833FE4CB6AQ30370553-0FB38302-5A76-4137-9620-E4229CE2488EQ30374041-8A085978-25DC-4959-8444-0D28AC2BFA92Q30381848-E6C978F9-DBF2-4D4B-9360-75CABA0F3A6CQ30413649-BF7FBA93-2384-40B3-96AE-1E296CA51A69Q30841272-1E01C238-5E9A-469C-B38A-B7508B466E26Q35822731-FAEB9E48-362E-45BF-B23F-DB010C78A8E3Q35841008-0671F778-36FC-4076-BFB3-FC03C04859F0Q36249593-F45CD330-4EF5-47B5-ADB0-72B399968B9FQ36361967-020B10D3-B9EB-4C25-92F0-8B5052F7597AQ36598125-2AEFDF69-A4F2-4555-9125-400998372709Q37683060-4F1CEBA7-D483-49CF-9C1B-642FA9056273Q38589482-599181AF-A90B-4728-8DCE-4A3D06900CE6Q40442973-9905879E-EF40-4710-99A2-11F06535E953Q40883476-0FB5EBB7-4946-4385-A5BE-116A0A8CDEF5Q41660878-8FE9179F-3AC5-4FCF-83FC-1F9C494BFBA9Q41906721-26EDD318-3227-4009-B8CF-C3FFF6336E6CQ42255068-11EE248A-E765-4CD4-A4F0-1BFC09BB3F6AQ42655015-87A799B8-A6B0-4F1B-A5CC-AB023F03EF59Q47244643-A25D5015-B97E-4BC2-B402-1C7E834E1C9FQ47282486-E71F3DAF-7D92-4D83-8B01-3E2BC0D142C6Q47304376-2BFE8B0E-CD60-424C-AB2F-637197FF2DB7Q47343453-934B0CAF-90B9-4FD4-BA3E-54332EC4147DQ47557168-ED0F382C-566D-488E-AE25-1503863980DDQ47884865-D4D1C83F-77D6-4F8B-86EC-126E6D47D7F3Q48092334-832FFB71-971C-4CD9-B13F-C6C3441CEB0AQ48196046-6D3CF70E-80AE-4580-A52F-0DAF05CCC778Q48457032-E0C140C6-F6D9-40E3-AD6C-FA8FD326BFA2Q49058754-B0BF4480-EA51-4356-A3F5-A1644AD3AC46Q49455604-50C90B51-2A84-4BA4-AC56-FC3D82E5EA5DQ50301218-1B24157C-BCBB-498B-A175-4E895DF450C8Q53423558-6BB58574-A679-4E37-855B-EECBE94DADC5Q55438998-874F9774-4202-4D9F-AA23-6DBEFBEDE8A6Q57173702-75E9DF14-14A3-4AE2-AC42-955490C861A5Q57465294-FDECBC4F-798E-46BB-859B-D5B6D84B6646Q58780865-E8372B28-B9A7-4ED4-AD0B-8A5740424D9AQ58782917-EDF4C3B6-C06C-44BB-B82B-708F1FF3DD7F
P2860
GABAergic signaling as therapeutic target for autism spectrum disorders
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
GABAergic signaling as therapeutic target for autism spectrum disorders
@ast
GABAergic signaling as therapeutic target for autism spectrum disorders
@en
GABAergic signaling as therapeutic target for autism spectrum disorders
@nl
type
label
GABAergic signaling as therapeutic target for autism spectrum disorders
@ast
GABAergic signaling as therapeutic target for autism spectrum disorders
@en
GABAergic signaling as therapeutic target for autism spectrum disorders
@nl
prefLabel
GABAergic signaling as therapeutic target for autism spectrum disorders
@ast
GABAergic signaling as therapeutic target for autism spectrum disorders
@en
GABAergic signaling as therapeutic target for autism spectrum disorders
@nl
P2860
P3181
P356
P1476
GABAergic signaling as therapeutic target for autism spectrum disorders
@en
P2093
Enrico Cherubini
P2860
P3181
P356
10.3389/FPED.2014.00070
P407
P50
P577
2014-01-01T00:00:00Z